Zheng Ren

Zheng Ren is currently working as the Director of Biostatistics at Cerevel Therapeutics since October 2021. Prior to this role, they served as the Associate Director of Biostatistics at Constellation Pharmaceuticals from March 2021 to December 2021. From June 2020 to March 2021, Zheng Ren worked as an Associate Director of Biostatistics at Biogen, where they also held the positions of Principal Biostatistician from June 2018 to June 2020 and Senior Biostatistician from December 2015 to June 2018. Before joining Biogen, Zheng Ren worked at PPD as a Biostatistician II from April 2015 to December 2015, Biostatistician from April 2013 to April 2015, and Associate Biostatistician from May 2012 to April 2013.

Zheng Ren has an extensive education history, starting with a Bachelor of Science (BS) degree in Mathematics and Physics from Tsinghua University, which was obtained between 2000 and 2004. Zheng then pursued a Master's degree in Physics from the same university, completing this program from 2004 to 2007.

Continuing the academic journey, Zheng enrolled at the University of North Carolina at Chapel Hill, where from 2009 to 2011, they obtained a Master's degree in Biostatistics. During this time, in 2009, Zheng also achieved certification as a SAS Certified Advanced Programmer for SAS9.

Zheng further deepened their knowledge by pursuing a Doctor of Philosophy (Ph.D.) degree in Engineering Physics/Applied Physics at the University of North Carolina at Chapel Hill, which was completed between 2007 and 2012.

In summary, Zheng holds a Bachelor of Science (BS) degree in Mathematics and Physics from Tsinghua University, a Master's degree in Physics from Tsinghua University, a Master's degree in Biostatistics from the University of North Carolina at Chapel Hill, and a Doctor of Philosophy (Ph.D.) degree in Engineering Physics/Applied Physics from the same university. Additionally, they obtained a SAS Certified Advanced Programmer for SAS9 certification in 2009.